{
  "author": {
    "name": "Amanda Bronstad",
    "webUrl": "/author/profile/amanda-bronstad/",
    "description": "Amanda Bronstad is the ALM staff reporter covering class actions and mass torts nationwide. She writes the email dispatch Law.com Class Actions: Critical Mass. She is based in Los Angeles.",
    "imageLarge": "https://secure.gravatar.com/avatar/fa0eb4371c9b77fcd6f8baa371474520?s=136&d=mm&r=g",
    "estimate": 39,
    "social": [
      {
        "network": "twitter",
        "value": "@abronstadlaw"
      },
      {
        "network": "linkedin",
        "value": "https://www.linkedin.com/feed/?trk=nav_back_to_linkedin"
      },
      {
        "network": "facebook",
        "value": "https://www.facebook.com/"
      },
      {
        "network": "googlePlus",
        "value": ""
      }
    ],
    "articles": [
      {
        "uri": "/2024/04/26/as-eli-lillys-insulin-pricing-settlement-unravels-lawyers-vow-to-push-ahead-412-166663/",
        "title": "Eli Lilly's $35 insulin cap could unravel, as $13.5M class action settlement falls apart",
        "byline": "Amanda Bronstad",
        "kicker": "News",
        "prettyDate": "April 26, 2024",
        "timeToRead": "5 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2023/09/lilly-eli-headquarters-indianapolis-1-767x633-e1695312692916.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/amanda-bronstad/",
            "name": "Amanda Bronstad"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "Eli Lilly had agreed to cap the price of insulin at $35 per month for 4 years and provide a $13.5 million cash fund, however, a dozen state attorneys general, some with their own insulin lawsuits, had objected to the settlement.",
        "body": null
      },
      {
        "uri": "/2024/03/25/social-media-ads-inject-new-angle-in-ozempic-cases-its-going-to-be-a-huge-focus-412-164189/",
        "title": "'Misleading' social media weight loss ads: Should drugmakers be liable in court?",
        "byline": "Amanda Bronstad",
        "kicker": "News",
        "prettyDate": "March 25, 2024",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2024/03/Social-Media-Article-202403201233.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/amanda-bronstad/",
            "name": "Amanda Bronstad"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "The proliferation of advertising on social media for Ozempic, Wegovy and other weight loss drugs will be a key part of the upcoming \"stomach paralysis\" lawsuits against Novo Nordisk and Eli Lilly.",
        "body": null
      },
      {
        "uri": "/2023/09/12/kroger-agrees-to-pay-1-2b-to-settle-opioid-lawsuits-412-154123/",
        "title": "Kroger grocery chain to pay $1.2B to settle opioid lawsuits with cities and states",
        "byline": "Amanda Bronstad",
        "kicker": "News",
        "prettyDate": "September 12, 2023",
        "timeToRead": "2 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2023/09/Kroger-Supermarket-Article-202309111244.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/amanda-bronstad/",
            "name": "Amanda Bronstad"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "Following opioid settlements announced by CVS, Walgreens and Walmart, the retailer announced the settlement, after a number of lawsuits claimed the grocery chain helped fuel the opioid epidemic.",
        "body": null
      },
      {
        "uri": "/2022/08/19/we-got-a-good-chunk-of-the-moon-650m-opioid-order-against-cvs-walmart-walgreens-412-134812/",
        "title": "Judge orders CVS, Walmart and Walgreens to fund $650M opioid abatement",
        "byline": "Amanda Bronstad",
        "kicker": "",
        "prettyDate": "August 19, 2022",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/03/walgreens-pharmacy-Article-201901222314.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/amanda-bronstad/",
            "name": "Amanda Bronstad"
          }
        ],
        "kickerNode": [],
        "summary": "U.S. District Judge Dan Polster, on Wednesday, ordered the three pharmacies to provide abatement funds to two Ohio counties who won a Nov. 23 verdict over the opioid crisis.",
        "body": null
      },
      {
        "uri": "/2022/08/01/opioid-manufacturer-teva-pharmaceuticals-reaches-4-25b-global-settlement-412-133777/",
        "title": "Opioid manufacturer Teva Pharmaceuticals reaches $4.25B global settlement",
        "byline": "Amanda Bronstad",
        "kicker": "",
        "prettyDate": "August 01, 2022",
        "timeToRead": "4 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2022/07/Teva-Pharmaceutical-Adam-Reynolds-Bloom-767x633.jpg",
          "width": "767",
          "height": "633"
        },
        "authors": [
          {
            "webUrl": "/author/profile/amanda-bronstad/",
            "name": "Amanda Bronstad"
          }
        ],
        "kickerNode": [],
        "summary": "Under the settlement, announced on Tuesday, Teva would provide $3.7 billion to states, local communities and Native American tribes, plus $1.2 billion worth of generic Narcan, a nasal spray used to treat opioid overdoses.",
        "body": null
      },
      {
        "uri": "/2022/07/04/oklahoma-settles-opioid-lawsuit-for-250million-412-132331/",
        "title": "Oklahoma settles opioid lawsuit for $250 million",
        "byline": "Amanda Bronstad",
        "kicker": "News",
        "prettyDate": "July 04, 2022",
        "timeToRead": "3 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2022/06/Opiod_Fees-767x633.jpg",
          "width": "767",
          "height": "633"
        },
        "authors": [
          {
            "webUrl": "/author/profile/amanda-bronstad/",
            "name": "Amanda Bronstad"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "The settlement comes after the state's Supreme Court reversed a $465M judgment the state obtained against Johnson & Johnson's Janssen Pharmaceuticals.",
        "body": null
      },
      {
        "uri": "/2022/05/09/walgreens-683-million-opioid-settlement-halts-florida-trial-412-129897/",
        "title": "Walgreens to pay $683M to settle Florida opioid lawsuit",
        "byline": "Amanda Bronstad",
        "kicker": "News",
        "prettyDate": "May 09, 2022",
        "timeToRead": "4 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/03/walgreens-pharmacy-Article-201901222314.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/amanda-bronstad/",
            "name": "Amanda Bronstad"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "Walgreens is the final defendant to settle in Florida's opioid case, bringing the state's total litigation wins to more than $3 billion.",
        "body": null
      },
      {
        "uri": "/2022/04/29/we-are-not-purdue-drugmakers-deny-blame-for-san-franciscos-opioid-crisis-412-129611/",
        "title": "Drug companies 'made a mockery' of opioid laws",
        "byline": "Amanda Bronstad",
        "kicker": "News",
        "prettyDate": "April 29, 2022",
        "timeToRead": "7 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2022/04/Opiod_Fees-767x633.jpg",
          "width": "767",
          "height": "633"
        },
        "authors": [
          {
            "webUrl": "/author/profile/amanda-bronstad/",
            "name": "Amanda Bronstad"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "San Francisco's opioid trial began this week, with drug companies insisting that Purdue Pharma should shoulder the blame for the crisis.",
        "body": null
      },
      {
        "uri": "/2022/02/28/drug-companies-move-forward-on-26b-opioid-deal-412-127418/",
        "title": "Drug companies move forward on $26B opioid deal",
        "byline": "Amanda Bronstad",
        "kicker": "News",
        "prettyDate": "February 28, 2022",
        "timeToRead": "5 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/06/opioid-abuse-crop.jpg",
          "width": "600",
          "height": "338"
        },
        "authors": [
          {
            "webUrl": "/author/profile/amanda-bronstad/",
            "name": "Amanda Bronstad"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "Johnson & Johnson and three drug distributors agreed to move forward with the second-largest multistate settlement in U.S. history.",
        "body": null
      },
      {
        "uri": "/2021/11/11/oklahoma-supreme-court-tosses-465m-opioid-judgment-412-123685/",
        "title": "Oklahoma Supreme Court reverses $465M opioid judgment",
        "byline": "Amanda Bronstad",
        "kicker": "News",
        "prettyDate": "November 11, 2021",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2021/11/Opioid-767x633-1.jpg",
          "width": "767",
          "height": "633"
        },
        "authors": [
          {
            "webUrl": "/author/profile/amanda-bronstad/",
            "name": "Amanda Bronstad"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "A majority opinion found the district judge \"went too far\" in extending Oklahoma's public nuisance law.",
        "body": null
      }
    ]
  }
}